BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29562423)

  • 1. [Value of N-terminal pro-B-type natriuretic peptide on long-term outcome of patients with hypertrophic cardiomyopathy].
    Meng XB; Wang WY; Zhang K; Qi Y; An SM; Wang SY; Zheng JL; Yu QJ; Tang B; Wu R; Wang SY; Gao CY; Tang YD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Mar; 46(3):192-197. PubMed ID: 29562423
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy.
    Coats CJ; Gallagher MJ; Foley M; O'Mahony C; Critoph C; Gimeno J; Dawnay A; McKenna WJ; Elliott PM
    Eur Heart J; 2013 Aug; 34(32):2529-37. PubMed ID: 23455360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
    Wess G; Daisenberger P; Mahling M; Hirschberger J; Hartmann K
    Vet Clin Pathol; 2011 Jun; 40(2):237-44. PubMed ID: 21434959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.
    D'Amato R; Tomberli B; Castelli G; Spoladore R; Girolami F; Fornaro A; Caldini A; Torricelli F; Camici P; Gensini GF; Cecchi F; Olivotto I
    Am J Cardiol; 2013 Oct; 112(8):1190-6. PubMed ID: 23871673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.
    Fox PR; Rush JE; Reynolds CA; Defrancesco TC; Keene BW; Atkins CE; Gordon SG; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Macdonald KA; Lehmkuhl LB; Nguyenba TP; Sydney Moise N; Lefbom BK; Hogan DF; Oyama MA
    J Vet Intern Med; 2011; 25(5):1010-6. PubMed ID: 21985136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-brain natriuretic peptide and adverse outcomes in Chinese patients with hypertrophic cardiomyopathy.
    Zhang ZL; Xu YY; Qin Z; Lu YZ; Liu TD; Zhang L; Shangguan JH; Wang W; Tang JN; Zhang JY
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34940836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome.
    Stiermaier T; Santoro F; Graf T; Guastafierro F; Tarantino N; De Gennaro L; Caldarola P; Di Biase M; Thiele H; Brunetti ND; Möller C; Eitel I
    Clin Res Cardiol; 2018 Jul; 107(7):597-606. PubMed ID: 29675571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Bégué C; Mörner S; Brito D; Hengstenberg C; Cleland JGF; Arbustini E; Galve E; Wichter T; Richter A; Golmard JL; Bernard M; Dubourg O; Komajda M; Charron P; Isnard R
    Heart; 2020 Feb; 106(3):196-202. PubMed ID: 31350276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy.
    Wu G; Liu J; Wang S; Yu S; Zhang C; Wang D; Zhang M; Yang Y; Kang L; Zhao S; Hui R; Zou Y; Wang J; Song L
    Heart; 2021 Oct; 107(19):1576-1583. PubMed ID: 33361398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy.
    Sahin I; Gungor B; Ozkaynak B; Uzun F; Küçük SH; Avci II; Ozal E; Ayça B; Cetın S; Okuyan E; Dinckal MH
    Clin Cardiol; 2017 Jan; 40(1):32-37. PubMed ID: 27768229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictive value of admission amino-terminal pro-B-type natriuretic peptide on in-hospital mortality in patients with decompensated heart failure].
    Wei BQ; Yang YJ; Zhang J; Dou KF; Zhang YH; Huang XH; Kang LM; Zhang CL; Gu Q; Gao X; Yang YM; Dai Y; Yu LT; Zhang HM; Lü R
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):481-5. PubMed ID: 19927625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
    Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
    Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino-terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz Peripheral Arterial Disease Study.
    Mueller T; Dieplinger B; Poelz W; Endler G; Wagner OF; Haltmayer M
    Clin Chem; 2009 Jan; 55(1):68-77. PubMed ID: 18988753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide.
    Nordling P; Kiviniemi T; Strandberg M; Strandberg N; Airaksinen J
    BMJ Open; 2016 Feb; 6(2):e009416. PubMed ID: 26911583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S; Webb MC; Price CP; John RI; Abbas NA; Lamb EJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3546-53. PubMed ID: 18562472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
    Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C
    Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.
    Feringa HH; Schouten O; Dunkelgrun M; Bax JJ; Boersma E; Elhendy A; de Jonge R; Karagiannis SE; Vidakovic R; Poldermans D
    Heart; 2007 Feb; 93(2):226-31. PubMed ID: 16914484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
    Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
    Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.